Xeraya Capital logo

Xeraya Capital

Asia, Kuala Lumpur, Malaysia, Kuala Lumpur

Description

Xeraya Capital is a private equity and venture capital firm.

Investor Profile

Xeraya Capital has made 23 investments, with 0 in the past 12 months and 22% as lead.

Stage Focus

  • Series C (26%)
  • Series B (26%)
  • Series D (13%)
  • Post Ipo Equity (13%)
  • Private Equity (9%)
  • Series Unknown (9%)
  • Series A (4%)

Country Focus

  • United States (91%)
  • United Kingdom (4%)
  • Germany (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Manufacturing
  • Medical Device
  • Therapeutics
  • Life Science
  • Medical
  • Health Diagnostics
  • Renewable Energy
  • Agriculture
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xeraya Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Madison Partners
North America, California, United States, Los Angeles
Co-Investments: 3
Pura Vida Investments
North America, New York, United States, New York
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 3
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
City Hill Ventures
North America, California, United States, San Diego
Co-Investments: 3
Delos Capital
North America, New York, United States, New York
Co-Investments: 3
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Spruce Capital Partners
North America, California, United States, San Francisco
Co-Investments: 3
GE Ventures
North America, California, United States, Menlo Park
Co-Investments: 3

Which angels does Xeraya Capital often collaborate with?

AG
Europe, Berlin, Germany, Berlin
Shared Deals: 1
Ilan Israelstam
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1

What are some of recent deals done by Xeraya Capital?

Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Post Ipo EquityFeb 3, 2022
Amount Raised: $125,500,000
OncoMyx Therapeutics

Phoenix, Arizona, United States

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
Series BDec 9, 2021
Amount Raised: $50,000,000
Viron

Boston, Massachusetts, United States

Viron Inc. is based in Boston, MA

Health Care
Series BDec 8, 2021
Amount Raised: $50,000,000
Imago BioSciences

San Carlos, California, United States

Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.

BiotechnologyLife ScienceTherapeutics
Series CNov 19, 2020
Amount Raised: $80,000,000
InterVenn

South San Francisco, California, United States

InterVenn unlocks the glycoproteome using artificial intelligence for the development of transformational healthcare solutions in DX and Rx.

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMedical
Series BNov 16, 2020
Amount Raised: $34,000,000
Congenica

Cambridge, Cambridgeshire, United Kingdom

Congenica is a biotechnology company that provides a diagnostic decision support platform.

BioinformaticsBiotechnologyGeneticsHealth CareMedical
Series CNov 9, 2020
Amount Raised: $50,000,000
Rapid Micro Biosystems

Bedford, Massachusetts, United States

Rapid Micro Biosystems offers tools that detect microbial contamination in manufacturing pharmaceutical, biotechnology and other products.

BiotechnologyManufacturingPharmaceutical
Private EquityMay 20, 2020
Amount Raised: $120,000,000
Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Series UnknownMay 12, 2020
Amount Raised: $17,000,000
Aria CV

Saint Paul, Minnesota, United States

Aria CV is developing a medical device designed to improve the lives of patients living with the disease of pulmonary hypertension.

Health CareMedical DeviceWellness
Series BFeb 25, 2020
Amount Raised: $31,000,000
P2 Science

Woodbridge, Connecticut, United States

P2 Science develops a bio-refining process for the conversion of biomass such as vegetable oils into high-value specialty chemicals.

BiotechnologyChemicalRenewable Energy
Series CJan 29, 2020
Amount Raised: $12,000,000